Evolv Technologies Holdings (EVLV) EBT (2020 - 2026)

Evolv Technologies Holdings has disclosed EBT across 7 years of filings, most recently posting -$9.3 million for Q2 2026.

• In Q2 2026, EBT rose 77.06% year-over-year to -$9.3 million; the TTM figure through Jun 2026 stood at -$5.3 million (up 94.05% YoY), while the FY2025 annual figure was -$33.1 million, up 38.77% from the prior year.
• EBT came in at -$9.3 million for Q2 2026 at Evolv Technologies Holdings, down from -$5.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $10.9 million in Q4 2025 to a low of -$67.2 million in Q2 2023.
• Average EBT over 5 years is -$17.3 million, with a median of -$16.4 million recorded in 2023.
• The largest YoY upside for EBT was 169.22% in 2025 against a maximum downside of 1285.96% in 2025.
• Over 5 years, EBT stood at -$25.3 million in 2022, then soared by 32.26% to -$17.1 million in 2023, then grew by 8.32% to -$15.7 million in 2024, then soared by 169.22% to $10.9 million in 2025, then plunged by 185.44% to -$9.3 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$9.3 million in Q2 2026, -$5.0 million in Q1 2026, and $10.9 million in Q4 2025.